AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10854683 — intervention group
Group type: COMPARATOR
Intervention: 10 mg isradipine
Number of subjects: 102
Study 10854683 — intervention group
Group type: COMPARATOR
Intervention: enalapril
Number of subjects: 102
Study 10854683 — intervention group
Group type: COMPARATOR
Intervention: isradipine
Number of subjects: 102
Study 10854683 — intervention group
Group type: EXPERIMENTAL
Intervention: combination of isradipine plus enalapril
Number of subjects: 102
Study 10854683 — intervention group
Group type: COMPARATOR
Intervention: all groups
Number of subjects: 102
Study 8617897 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise program (walking, wheelchair movement training, rowing exercise three times per week)
Number of subjects: 97
Study 8617897 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise intervention)
Number of subjects: 97
Study 1425871 — intervention group
Group type: EXPERIMENTAL
Intervention: Acipimox 250 mg
Number of subjects: 74
Study 1425871 — intervention group
Group type: EXPERIMENTAL
Intervention: Acipimox (doses: 31.2, 62.5, 125.0, 250.0 mg)
Number of subjects: 74
Study 1425871 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study 6378522 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (325 mg t.i.d.) and dipyridamole (75 mg t.i.d.)
Number of subjects: 231
Study 6378522 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 231
Study 6378522 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin and dipyridamole
Number of subjects: 231
Study 30922083 — intervention group
Group type: EXPERIMENTAL
Intervention: Tooth-clenching task
Number of subjects: 70
Study 30922083 — intervention group
Group type: COMPARATOR
Intervention: Control task
Number of subjects: 70
Study 29995589 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-and-coping-oriented basic palliative homecare intervention (six visits within 15 weeks)
Number of subjects: 57
Study 29995589 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 57
Study 26853497 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behaviour treatment program (Cool Kids)
Number of subjects: 98
Study 26853497 — intervention group
Group type: EXPERIMENTAL
Intervention: Homework adherence (measured as time spent doing homework assignments)
Number of subjects: 98
Study 24525115 — intervention group
Group type: EXPERIMENTAL
Intervention: MOSF (15% Fish oil, 30% Medium‐chain triglycerides, 25% Olive oil, 30% Soybean oil) at 3.5 g kg(‐1) d(‐1)
Number of subjects: 80
Study 24525115 — intervention group
Group type: EXPERIMENTAL
Intervention: MOSF (15% Fish oil) at 2.5 g kg(‐1) d(‐1)
Number of subjects: 80
Study 24525115 — intervention group
Group type: EXPERIMENTAL
Intervention: MOSF (15% Fish oil)
Number of subjects: 80
Study 24525115 — intervention group
Group type: COMPARATOR
Intervention: S (100% Soybean oil)
Number of subjects: 80
Study 22310249 — intervention group
Group type: EXPERIMENTAL
Intervention: 370 MBq ¹³¹I
Number of subjects: 76
Study 22310249 — intervention group
Group type: EXPERIMENTAL
Intervention: 555 MBq ¹³¹I
Number of subjects: 76
Study 19642480 — intervention group
Group type: EXPERIMENTAL
Intervention: Healing Touch
Number of subjects: 784
Study 19642480 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 784
Study 17462166 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional physiotherapy from a physiotherapy assistant for 1 hour per week for 6 months
Number of subjects: 76
Study 17462166 — intervention group
Group type: COMPARATOR
Intervention: Standard physiotherapy
Number of subjects: 76
Study 17462166 — intervention group
Group type: COMPARATOR
Intervention: Standard physiotherapy plus family support worker visits
Number of subjects: 76
Study 15235056 — intervention group
Group type: EXPERIMENTAL
Intervention: Renal transplantation
Number of subjects: 13
Study 15235056 — intervention group
Group type: COMPARATOR
Intervention: Control subjects (no intervention)
Number of subjects: 13
Study 11243591 — intervention group
Group type: COMPARATOR
Intervention: 20 microg recombinant HBsAg (rHBsAg)
Number of subjects: 77
Study 11243591 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 microg recombinant HBsAg (rHBsAg)
Number of subjects: 77
Study 9203891 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% lignocaine gel
Number of subjects: 126
Study 9203891 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 126
Study 8388918 — intervention group
Group type: EXPERIMENTAL
Intervention: Vincristine (VCR) and Dactinomycin (AMD) for 17 weeks (S)
Number of subjects: 509
Study 8388918 — intervention group
Group type: EXPERIMENTAL
Intervention: Vincristine (VCR) and Dactinomycin (AMD) for 38 weeks (L)
Number of subjects: 509
Study 8388918 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 Gy irradiation (R+) with VCR and AMD for 38 weeks
Number of subjects: 509
Study 8388918 — intervention group
Group type: COMPARATOR
Intervention: No irradiation (R-) with VCR and AMD for 38 weeks
Number of subjects: 509
Study 8388918 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensified VCR and AMD (INTVCR)
Number of subjects: 509
Study 8388918 — intervention group
Group type: COMPARATOR
Intervention: VCR, AMD, and Adriamycin (ADRIA)
Number of subjects: 509
Study 3551160 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple chemotherapeutic agents
Number of subjects: 81
Study 3551160 — intervention group
Group type: COMPARATOR
Intervention: Single chemotherapeutic agents
Number of subjects: 81
Study 31112370 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive Lifestyle Intervention (ILI)
Number of subjects: 232
Study 31112370 — intervention group
Group type: COMPARATOR
Intervention: Diabetes Support and Education (DSE)
Number of subjects: 232
Study 28587665 — intervention group
Group type: EXPERIMENTAL
Intervention: PRACTICE clinical prediction rule (guidance on hospitalization for high risk patients >100 points and home discharge for low risk patients <75 points)
Number of subjects: 370
Study 28587665 — intervention group
Group type: EXPERIMENTAL
Intervention: PRACTICE clinical prediction rule
Number of subjects: 370
Study 28587665 — intervention group
Group type: COMPARATOR
Intervention: Standard policy regarding hospital admission (control group)
Number of subjects: 370
Study 27213447 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D₃ supplementation with a standardized high-fat breakfast
Number of subjects: 88
Study 27213447 — intervention group
Group type: COMPARATOR
Intervention: Vitamin D₃ supplementation in fasting state
Number of subjects: 88
Study 25086150 — intervention group
Group type: EXPERIMENTAL
Intervention: Online interactive training module
Number of subjects: 72
Study 25086150 — intervention group
Group type: COMPARATOR
Intervention: Traditional lecture‐based presentation
Number of subjects: 72
Study 21853386 — intervention group
Group type: EXPERIMENTAL
Intervention: Clodronate 300 mg i.v. for 7 days, followed by clodronate i.m. 100 mg for 14 days every 3 months (Group A)
Number of subjects: 38
Study 21853386 — intervention group
Group type: COMPARATOR
Intervention: Hydroxychloroquine 400 mg daily for 30 days, followed by 200 mg daily for the next 11 months (Group B)
Number of subjects: 38
Study 21853386 — intervention group
Group type: COMPARATOR
Intervention: Comparison between Clodronate (Group A) and Hydroxychloroquine (Group B)
Number of subjects: 38
Study 19910725 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate (TP)
Number of subjects: 63
Study 19910725 — intervention group
Group type: COMPARATOR
Intervention: Placebo (C)
Number of subjects: 63
Study 17209695 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate exercise
Number of subjects: 64
Study 17209695 — intervention group
Group type: COMPARATOR
Intervention: Sedentary activity
Number of subjects: 64
Study 15649655 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 cups (450 mL) of filtered coffee for 3 weeks
Number of subjects: 43
Study 15649655 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 cups (900 mL) of filtered coffee for 3 weeks
Number of subjects: 43
Study 15649655 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 cup (150 mL) of coffee (single dose)
Number of subjects: 43
Study 15649655 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 cups (300 mL) of coffee (single dose)
Number of subjects: 43
Study 15649655 — intervention group
Group type: COMPARATOR
Intervention: No coffee (control group for long-term trial)
Number of subjects: 43
Study 15649655 — intervention group
Group type: COMPARATOR
Intervention: 0 cups (control group for short-term study)
Number of subjects: 43
Study 12469330 — intervention group
Group type: EXPERIMENTAL
Intervention: Colestipol hydrochloride (colestipol) administered with diltiazem SR
Number of subjects: 12
Study 12469330 — intervention group
Group type: COMPARATOR
Intervention: Diltiazem SR alone
Number of subjects: 12
Study 10341854 — intervention group
Group type: EXPERIMENTAL
Intervention: Interleukin-2 treatment
Number of subjects: 8
Study 7497581 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide
Number of subjects: 0
Study 7497581 — intervention group
Group type: EXPERIMENTAL
Intervention: Propantheline
Number of subjects: 0
Study 7497581 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol or bile salts
Number of subjects: 0
Study 7497581 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 0
Study 1773329 — intervention group
Group type: EXPERIMENTAL
Intervention: Haemonetics Cell Saver
Number of subjects: 12
Study 1773329 — intervention group
Group type: EXPERIMENTAL
Intervention: Solcotrans device
Number of subjects: 12
Study 7175960 — intervention group
Group type: EXPERIMENTAL
Intervention: Social Skills Training (SST)
Number of subjects: 29
Study 7175960 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Restructuring (CR)
Number of subjects: 29
Study 7175960 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined SST and CR
Number of subjects: 29
Study 7175960 — intervention group
Group type: COMPARATOR
Intervention: Nondirective placebo discussion group
Number of subjects: 29
Study 31775085 — intervention group
Group type: EXPERIMENTAL
Intervention: Emailed radiology alerts (RadAlert system) after educational intervention
Number of subjects: 100
Study 31775085 — intervention group
Group type: EXPERIMENTAL
Intervention: Emailed radiology alerts (RadAlert system) both before and after educational intervention
Number of subjects: 100
Study 30264364 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary vein isolation with ablation of the anterior mitral line (after ablation)
Number of subjects: 41
Study 30264364 — intervention group
Group type: COMPARATOR
Intervention: Control group (without ablation)
Number of subjects: 41
Study 28668539 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-FODMAP diet
Number of subjects: 92
Study 28668539 — intervention group
Group type: COMPARATOR
Intervention: mNICE diet
Number of subjects: 92
Study 26459421 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive BP lowering (systolic BP <120 mm Hg)
Number of subjects: 4331
Study 26459421 — intervention group
Group type: COMPARATOR
Intervention: Standard BP lowering (systolic BP <140 mm Hg)
Number of subjects: 4331
Study 23606340 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression (IPC)
Number of subjects: 10
Study 23606340 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 10
Study 21482474 — intervention group
Group type: EXPERIMENTAL
Intervention: S(+)‐ketamine (0.5mg/kg, n=12)
Number of subjects: 24
Study 21482474 — intervention group
Group type: COMPARATOR
Intervention: Midazolam (5mg, n=12)
Number of subjects: 24
Study 19854333 — intervention group
Group type: COMPARATOR
Intervention: No counseling (NC)
Number of subjects: 4875
Study 19854333 — intervention group
Group type: COMPARATOR
Intervention: 1 counseling session (1C)
Number of subjects: 4875
Study 19854333 — intervention group
Group type: COMPARATOR
Intervention: 3 counseling sessions (3C)
Number of subjects: 4875
Study 17803064 — intervention group
Group type: EXPERIMENTAL
Intervention: HEP1 (human ezrin peptide 324‐337; TEKKRRETVEREKE) monotherapy
Number of subjects: 37
Study 15298640 — intervention group
Group type: EXPERIMENTAL
Intervention: Rabeprazole 20 mg once daily for 4-8 weeks
Number of subjects: 1787
Study 11104181 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure with guided threat reappraisal
Number of subjects: 58
Study 11104181 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure with cognitive load distracter task
Number of subjects: 58
Study 11104181 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure with both guided threat reappraisal and cognitive load distracter task
Number of subjects: 58
Study 11104181 — intervention group
Group type: COMPARATOR
Intervention: Exposure without guided threat reappraisal or cognitive load distracter task
Number of subjects: 58
Study 8880815 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral transmucosal ketamine (5‐6 mg.kg‐1)
Number of subjects: 25
Study 8880815 — intervention group
Group type: COMPARATOR
Intervention: Intranasal ketamine (5‐6 mg.kg‐1)
Number of subjects: 25
Study 8880815 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 8880815 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular ketamine (5‐6 mg.kg‐1)
Number of subjects: 25
Study 1440160 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal membrane oxygenation (ECMO)
Number of subjects: 0
Study 3930990 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose naloxone (2 mg/kg)
Number of subjects: 0
Study 3930990 — intervention group
Group type: COMPARATOR
Intervention: Low dose naloxone (0.4 mg, approx. 5 micrograms/kg)
Number of subjects: 0
Study 3663882 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg controlled-release (CR) albuterol tablet (q12h)
Number of subjects: 12
Study 3663882 — intervention group
Group type: COMPARATOR
Intervention: 2 mg conventional albuterol tablet (q6h)
Number of subjects: 12
Study 31665385 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily supplementation with an egg and 150 mL of cow milk for 90 days, and 1 sachet of multiple micronutrient powder for 60 days.
Number of subjects: 472
Study 31665385 — intervention group
Group type: COMPARATOR
Intervention: Control group (no nutrition intervention).
Number of subjects: 472
Study 29311671 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based exercise training (HET), moderate to high intensity cycling exercise, 3 days/week for 8 weeks
Number of subjects: 40
Study 29311671 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 40
Study 27220978 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspiration thrombectomy with intracoronary tirofiban (Group B)
Number of subjects: 150
Study 27220978 — intervention group
Group type: COMPARATOR
Intervention: Aspiration thrombectomy (Group A)
Number of subjects: 150
Study 26434920 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 months healing time
Number of subjects: 51
Study 26434920 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 months healing time
Number of subjects: 51
Study 22147646 — intervention group
Group type: EXPERIMENTAL
Intervention: Open Window (art intervention)
Number of subjects: 199
Study 22147646 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 199
Study 20463260 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (tailored exercise prescription + transtheoretical behavior change counseling)
Number of subjects: 360
Study 20463260 — intervention group
Group type: COMPARATOR
Intervention: Control group (exercise prescription alone)
Number of subjects: 360
Study 18704481 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback training (unilateral EMG biofeedback from the dominant trapezius)
Number of subjects: 164
Study 18704481 — intervention group
Group type: COMPARATOR
Intervention: Control group (working with computer mouse more than 50%)
Number of subjects: 164
Study 16629967 — intervention group
Group type: EXPERIMENTAL
Intervention: Access to bed-chair pressure sensors
Number of subjects: 180
Study 12701337 — intervention group
Group type: EXPERIMENTAL
Intervention: APAP treatment (n = 50)
Number of subjects: 100
Study 12701337 — intervention group
Group type: COMPARATOR
Intervention: Conventional CPAP treatment (n = 50)
Number of subjects: 100
Study 10744824 — intervention group
Group type: EXPERIMENTAL
Intervention: Optical coherence tomography during routine upper GI endoscopy
Number of subjects: 32
Study 9557050 — intervention group
Group type: EXPERIMENTAL
Intervention: Mucosolvan (mucolytic preparation)
Number of subjects: 60
Study 1304021 — intervention group
Group type: EXPERIMENTAL
Intervention: Spiramycin (1 gram twice daily)
Number of subjects: 120
Study 1304021 — intervention group
Group type: COMPARATOR
Intervention: Erythromycin (500 mg thrice or four times daily)
Number of subjects: 120
Study 3903239 — intervention group
Group type: EXPERIMENTAL
Intervention: Ribavirin (14 infants)
Number of subjects: 53
Study 3903239 — intervention group
Group type: COMPARATOR
Intervention: Placebo (12 infants)
Number of subjects: 53
Study 31419449 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity acute aerobic exercise (n=22; 65%-75% HRmax)
Number of subjects: 44
Study 31419449 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity acute aerobic exercise (n=22; ≥ 85% HRmax)
Number of subjects: 44
Study 31419449 — intervention group
Group type: COMPARATOR
Intervention: Control session (resting)
Number of subjects: 44
Study 30574757 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous nursing care including indirect follow‐up, health education, and home visit
Number of subjects: 80
Study 30574757 — intervention group
Group type: COMPARATOR
Intervention: Control group (no continuous nursing intervention)
Number of subjects: 80
Study 30574757 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous nursing care
Number of subjects: 80
Study 27010957 — intervention group
Group type: EXPERIMENTAL
Intervention: Omalizumab 300 mg every 4 weeks up to week 24
Number of subjects: 91
Study 27010957 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study 27010957 — intervention group
Group type: EXPERIMENTAL
Intervention: Omalizumab 300 mg
Number of subjects: 91
Study 24296715 — intervention group
Group type: EXPERIMENTAL
Intervention: DPP-4 inhibition
Number of subjects: 24
Study 24296715 — intervention group
Group type: COMPARATOR
Intervention: GLP-1 receptor antagonist (exendin-9)
Number of subjects: 24
Study 23764140 — intervention group
Group type: EXPERIMENTAL
Intervention: Contextual Cognitive Behavioural Therapy (CCBT)
Number of subjects: 92
Study 23764140 — intervention group
Group type: COMPARATOR
Intervention: Treatment As Usual (TAU) physiotherapy
Number of subjects: 92
Study 20339479 — intervention group
Group type: EXPERIMENTAL
Intervention: Västerbotten Intervention Programme (VIP)
Number of subjects: 113203
Study 18430909 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus-eluting stent
Number of subjects: 1002
Study 16374158 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-stay intensive care (SSIC) treatment (8 hrs of intensive care treatment)
Number of subjects: 600
Study 12803596 — intervention group
Group type: EXPERIMENTAL
Intervention: ProSeal Laryngeal Mask Airway (PLMA)
Number of subjects: 26
Study 14635284 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg twice a day of celecoxib
Number of subjects: 1149
Study 14635284 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg twice a day of celecoxib
Number of subjects: 1149
Study 14635284 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg twice a day of celecoxib
Number of subjects: 1149
Study 14635284 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg twice a day of naproxen
Number of subjects: 1149
Study 14635284 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1149
Study 9365356 — intervention group
Group type: EXPERIMENTAL
Intervention: Heavy social drinkers with TBI
Number of subjects: 40
Study 9365356 — intervention group
Group type: EXPERIMENTAL
Intervention: Nondrinking subjects with TBI
Number of subjects: 40
Study 9365356 — intervention group
Group type: COMPARATOR
Intervention: Heavy social drinkers without TBI
Number of subjects: 40
Study 9365356 — intervention group
Group type: COMPARATOR
Intervention: Nondrinking subjects without TBI
Number of subjects: 40
Study 1395983 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracolonic bypass
Number of subjects: 22
Study 1395983 — intervention group
Group type: COMPARATOR
Intervention: Ostomy (Control)
Number of subjects: 22
Study 3899029 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunotherapy (Levamisole and Intrapleural BCG)
Number of subjects: 258
Study 3899029 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy (CisPlatinum, Adriamycin, and Cytoxan)
Number of subjects: 258
Study 3899029 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative radiation therapy
Number of subjects: 258
Study 3899029 — intervention group
Group type: COMPARATOR
Intervention: No further treatment
Number of subjects: 258
Study 31515507 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration training (WBVT)
Number of subjects: 33
Study 31515507 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity resistance exercise training (LIRET)
Number of subjects: 33
Study 29411114 — intervention group
Group type: EXPERIMENTAL
Intervention: Second-generation cryoballoon ablation
Number of subjects: 269
Study 29411114 — intervention group
Group type: COMPARATOR
Intervention: Contact-force radiofrequency ablation
Number of subjects: 269
Study 27871565 — intervention group
Group type: EXPERIMENTAL
Intervention: Fascia iliaca block
Number of subjects: 71
Study 27871565 — intervention group
Group type: COMPARATOR
Intervention: Periarticular drug injection
Number of subjects: 71
Study 24281276 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg dronabinol
Number of subjects: 30
Study 24281276 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg dronabinol
Number of subjects: 30
Study 24281276 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 22511794 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate infusion in thyroidectomized patients
Number of subjects: 60
Study 22511794 — intervention group
Group type: COMPARATOR
Intervention: Sodium bicarbonate infusion in healthy volunteers
Number of subjects: 60
Study 20122281 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised, twice weekly exercise training with regular review of airway clearance therapy
Number of subjects: 64
Study 20122281 — intervention group
Group type: COMPARATOR
Intervention: Twice weekly telephone support
Number of subjects: 64
Study 18772264 — intervention group
Group type: EXPERIMENTAL
Intervention: Nuss technique
Number of subjects: 20